The partnership will see the implementation of RISQ (data quality product) across the CALHN network of hospitals, the launch of a new trial using RippleDown® (AI decision support product) and the Ainsoff Index (which is used for early detection of deteriorating patients), and the opportunity to co-develop a new implementation of RippleDown® in clinical workflow.
Find out more about the partnership through the ASX release.
Share this article
We believe that CALHN is a fantastic partner to assist us in this trial and implementation of these ground-breaking AI decision support products. This strategic partnership is an outcome of our commitment to improving patient outcomes through the early identification of risk, benchmarking and AI-led decision support. Together, we have the opportunity to enhance healthcare service quality, safety, accuracy and insight that will improve health systems in Adelaide and beyond.”
